Emergent BioSolutions, Inc. (EBS)
5.09
-0.06
(-1.17%)
USD |
NYSE |
Nov 20, 15:35
Emergent BioSolutions 30-Day Average Daily Volume : 1.031M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 1.031M |
| November 18, 2026 | 1.036M |
| November 17, 2026 | 1.050M |
| November 16, 2026 | 1.083M |
| November 13, 2026 | 1.138M |
| November 12, 2026 | 1.132M |
| November 11, 2026 | 1.125M |
| November 10, 2026 | 1.134M |
| November 09, 2026 | 1.137M |
| November 06, 2026 | 1.131M |
| November 05, 2026 | 1.119M |
| November 04, 2026 | 1.097M |
| November 03, 2026 | 1.055M |
| November 02, 2026 | 990417.6 |
| October 30, 2026 | 1.009M |
| October 29, 2026 | 1.046M |
| October 28, 2026 | 1.070M |
| October 27, 2026 | 1.097M |
| October 26, 2026 | 1.081M |
| October 23, 2026 | 1.087M |
| October 22, 2026 | 1.106M |
| October 21, 2026 | 1.158M |
| October 20, 2026 | 1.169M |
| October 19, 2026 | 1.148M |
| October 16, 2026 | 1.154M |
| Date | Value |
|---|---|
| October 15, 2026 | 1.116M |
| October 14, 2026 | 1.129M |
| October 13, 2026 | 1.136M |
| October 12, 2026 | 1.154M |
| October 09, 2026 | 1.164M |
| October 08, 2026 | 1.179M |
| October 07, 2026 | 1.180M |
| October 06, 2026 | 1.184M |
| October 05, 2026 | 1.151M |
| October 02, 2026 | 1.120M |
| October 01, 2026 | 1.150M |
| September 30, 2026 | 1.176M |
| September 29, 2026 | 1.176M |
| September 28, 2026 | 1.174M |
| September 25, 2026 | 1.188M |
| September 24, 2026 | 1.215M |
| September 23, 2026 | 1.242M |
| September 22, 2026 | 1.265M |
| September 21, 2026 | 1.371M |
| September 18, 2026 | 1.426M |
| September 17, 2026 | 1.505M |
| September 16, 2026 | 1.483M |
| September 15, 2026 | 1.446M |
| September 14, 2026 | 1.427M |
| September 11, 2026 | 1.420M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.518M |
| Arcturus Therapeutics Holdings, Inc. | 652216.7 |
| Capricor Therapeutics, Inc. | 3.939M |
| Travere Therapeutics, Inc. | 2.007M |
| Syndax Pharmaceuticals, Inc. | 3.693M |